✦ LIBER ✦

Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine

✍ Scribed by Kedar V. Inamdar; Jorge E. Romaguera; Elias Drakos; Ronald J. Knoblock; Mar Garcia; Vasiliki Leventaki; L. Jeffrey Medeiros; George Z. Rassidakis

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 389 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24506

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proliferation predicts failure-free surv

Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine

✍ Mar Garcia; Jorge E. Romaguera; Kedar V. Inamdar; George Z. Rassidakis; L. Jeffr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views